SDEV vs. NVS
SDEV (Stablecoin Development Corporation) and NVS (Novartis AG) are both stocks. SDEV operates in Asset Management (Financial Services), while NVS operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SDEV returned -59.79%/yr vs 10.33%/yr for NVS. At a 0.03 correlation, their price movements are largely independent.
Performance
SDEV vs. NVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SDEV achieves a -95.89% return, which is significantly lower than NVS's 9.43% return. Over the past 10 years, SDEV has underperformed NVS with an annualized return of -59.79%, while NVS has yielded a comparatively higher 10.33% annualized return.
SDEV
- 1D
- 3.57%
- 1M
- -28.83%
- YTD
- -95.89%
- 6M
- -85.03%
- 1Y
- -39.49%
- 3Y*
- -75.48%
- 5Y*
- -79.20%
- 10Y*
- -59.79%
NVS
- 1D
- -1.84%
- 1M
- 0.27%
- YTD
- 9.43%
- 6M
- 15.91%
- 1Y
- 27.84%
- 3Y*
- 17.18%
- 5Y*
- 13.87%
- 10Y*
- 10.33%
SDEV vs. NVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SDEV Stablecoin Development Corporation | -95.89% | 1,319.69% | -91.58% | -89.54% | -85.21% | -45.97% | 8.91% | -17.17% | -79.93% | 16.67% |
NVS Novartis AG | 9.43% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
Correlation
The correlation between SDEV and NVS is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.03 |
Correlation (All Time) Calculated using the full available price history since Oct 29, 2007 | 0.03 |
Fundamentals
SDEV:
$192.22M
NVS:
$280.54B
SDEV:
$12.02
NVS:
$6.99
SDEV:
0.10
NVS:
20.95
SDEV:
20.47
NVS:
5.06
SDEV:
1.38
NVS:
7.28
SDEV:
$2.46M
NVS:
$56.05B
SDEV:
-$85.00K
NVS:
$42.19B
SDEV:
-$5.18M
NVS:
$22.40B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SDEV vs. NVS — Risk / Return Rank
SDEV
NVS
SDEV vs. NVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Stablecoin Development Corporation (SDEV) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SDEV | NVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.52 | ||
| Sortino ratioReturn per unit of downside risk | -0.30 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.24 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | -0.40 | 2.21 | -2.61 |
| Martin ratioReturn relative to average drawdown | -0.59 | 5.43 | -6.03 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SDEV | NVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.16 | 1.36 | -1.52 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.57 | 0.74 | -1.31 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.18 | 0.53 | -0.71 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.20 | 0.42 | -0.62 |
Drawdowns
SDEV vs. NVS - Drawdown Comparison
The maximum SDEV drawdown since its inception was -100.00%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for SDEV and NVS.
Loading charts...
Drawdown Indicators
| SDEV | NVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -42.10% | -57.90% |
Max Drawdown (1Y)Largest decline over 1 year | -98.83% | -12.65% | -86.18% |
Max Drawdown (3Y)Largest decline over 3 years | -98.89% | -19.95% | -78.94% |
Max Drawdown (5Y)Largest decline over 5 years | -99.96% | -20.42% | -79.54% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -26.03% | -73.96% |
Current DrawdownCurrent decline from peak | -100.00% | -10.52% | -89.48% |
Average DrawdownAverage peak-to-trough decline | -82.68% | -10.93% | -71.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 66.80% | 5.14% | +61.66% |
Volatility
SDEV vs. NVS - Volatility Comparison
Stablecoin Development Corporation (SDEV) has a higher volatility of 21.69% compared to Novartis AG (NVS) at 6.16%. This indicates that SDEV's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SDEV | NVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.69% | 6.16% | +15.53% |
Volatility (6M)Calculated over the trailing 6-month period | 185.11% | 14.45% | +170.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 244.75% | 20.63% | +224.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 140.43% | 18.85% | +121.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 333.78% | 19.62% | +314.16% |
Dividends
SDEV vs. NVS - Dividend Comparison
SDEV's dividend yield for the trailing twelve months is around 344.83%, more than NVS's 3.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 3.26% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
SDEV Stablecoin Development Corporation | 344.83% | 14.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SDEV vs. NVS - Financials Comparison
This section allows you to compare key financial metrics between Stablecoin Development Corporation and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SDEV and NVS have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SDEV has higher volatility (21.69%) compared to NVS (6.16%). In terms of maximum drawdown, SDEV dropped -100.00% vs NVS's -42.10%.
NVS currently has the higher Sharpe Ratio (1.36 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SDEV and NVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer